Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial.
Gabriela CedilloMary Catherine GeorgeRicha DeshpandeEmma K T BennAllison NavisAlexandra NmashieAlina SiddiquiBridget R MuellerYosuke ChikamotoLinda WeissMaya SchererAlexandra KamlerJudith A AbergBarbara G VickreyAngela BryanBrady HornAngela StarkweatherJeffrey FisherJessica Robinson-PappPublished in: Addiction science & clinical practice (2022)
CDC-guideline adherence can be promoted and measured, and is not associated with worsening of outcomes for people with HIV receiving LTOT for CP. Future work would be needed to document scalability of these results and to determine whether CDC-guideline adherence results in a positive effect on public health. Trial registration https://clinicaltrials.gov/ct2/show/NCT03669939 . Registration date: 9/13/2018.
Keyphrases
- public health
- study protocol
- antiretroviral therapy
- cell cycle
- hiv positive
- hiv infected
- primary care
- glycemic control
- human immunodeficiency virus
- hepatitis c virus
- chronic pain
- hiv testing
- phase iii
- pain management
- clinical trial
- hiv aids
- current status
- contrast enhanced
- randomized controlled trial
- emergency department
- type diabetes
- open label
- south africa
- skeletal muscle